Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aquarius Surgical TechnologiesAQQRF Receivables Turnover is 0.57 as of Dec. 2025. The stock has 4 warning signs investors should review. Among 811 Medical Devices & Instruments companies, Aquarius Surgical Technologies ranks worse than 93.59% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Aquarius Surgical Technologies's Revenue for the
three
months ended in Dec. 2025 was $0.02 Mil. Aquarius Surgical Technologies's average Accounts Receivable for the
three
months ended in Dec. 2025 was $0.03 Mil.
Hence, Aquarius Surgical Technologies's Receivables Turnover for the
three
months ended in Dec. 2025 was 0.57.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Aquarius Surgical Technologies Receivables Turnover Related Terms
Aquarius Surgical Technologies Receivables Turnover Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AQQRF vs ABT, SYK, MDT: Receivables Turnover Comparison
For the Medical Devices subindustry, Aquarius Surgical Technologies's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aquarius Surgical Technologies Receivables Turnover vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Aquarius Surgical Technologies's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Aquarius Surgical Technologies's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aquarius Surgical Technologies (AQQRF) has a Receivables Turnover of 0.57 as of Dec. 2025. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Aquarius Surgical Technologies and its competitors. According to the industry distribution chart, Aquarius Surgical Technologies ranks #759 out of 811 companies in the Medical Devices & Instruments industry, placing it in the top 93.6%.
Is Aquarius Surgical Technologies' Receivables Turnover too high?
Aquarius Surgical Technologies' current Receivables Turnover is 0.57. The Medical Devices & Instruments industry median Receivables Turnover is 5.51. Aquarius Surgical Technologies' value of 0.57 is 89.7% below this industry median. Based on the distribution chart, Aquarius Surgical Technologies ranks #759 out of 811 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does Aquarius Surgical Technologies' Receivables Turnover compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Aquarius Surgical Technologies ranks #759 out of 811 companies for Receivables Turnover. This places Aquarius Surgical Technologies in the lower half of its industry. The industry median Receivables Turnover is 5.51. Aquarius Surgical Technologies' value of 0.57 is 89.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Medical Devices & Instruments company?
The median Receivables Turnover among Medical Devices & Instruments companies is 5.51, based on 811 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aquarius Surgical Technologies's current Receivables Turnover of 0.57 is 89.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Aquarius Surgical Technologies and its competitors. For the Medical Devices & Instruments industry, the median Receivables Turnover is 5.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aquarius Surgical Technologies's current Receivables Turnover is 0.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aquarius Surgical Technologies stock overvalued right now?
Aquarius Surgical Technologies (AQQRF) has a current Receivables Turnover of 0.57. The current Receivables Turnover is 0.57 and 89.7% below the Medical Devices & Instruments industry median of 5.51. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Aquarius Surgical Technologies (AQQRF), the current Receivables Turnover is 0.57 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Aquarius Surgical Technologies Business Description
Aquarius Surgical Technologies Inc is engaged in the development, sale, distribution, marketing, and exploitation of laser-driven technologies for use in surgical environments. Through its subsidiary, the company operates as an international distributor, service, and support organization providing integrated laser-based solutions across multiple medical disciplines. These disciplines include urology, gynecology, ophthalmology, thoracic, ENT, cardiovascular, and neurosurgery, many of which are now considered the standard of care for treatment. Geographically, the company generates maximum revenue from the sale of medical devices in the United States, and also has its presence in Canada.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AQQRF has been successfully added to your 
